Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Modeling and Simulation in Medical Sciences: An Overview of Specific Applications Based on Research Experience in Emri (Endocrinology and Metabolism Research Institute of Tehran University of Medical Sciences) Publisher



Ebrahimhabibi A1 ; Kashaniamin E1 ; Larijani B2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Biosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Jalal-al-Ahmad Street, Chamran Highway, Tehran, 1411713137, Iran
  2. 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Diabetes and Metabolic Disorders Published:2021


Abstract

The concomitant use of various types of models (in silico, in vitro, and in vivo) has been exemplified here within the context of biomedical researches performed in the Endocrinology and Metabolism Research Institute (EMRI) of Tehran University of Medical Sciences. Two main research aeras have been discussed: the search for new small molecules as therapeutics for diabetes and related metabolic conditions, and diseases related to protein aggregation. Due to their multidisciplinary nature, the majority of these studies have needed the collaboration of different specialties. In both cases, a brief overview of the subject is provided through literature examples, and sequential use of these methods is described. © 2021, Springer Nature Switzerland AG.
Other Related Docs
20. Glycyrrhizin Improves Fatty Liver Symptoms, Increases Adiponectin and Reduces Ucp2 Expression in Wistar Rats, Proceedings of the National Academy of Sciences India Section B - Biological Sciences (2020)
25. Aurones As New Porcine Pancreatic Α-Amylase Inhibitors, Letters in Drug Design and Discovery (2019)
29. Heterocyclic Compounds: Effective Α-Amylase and Α-Glucosidase Inhibitors, Current Topics in Medicinal Chemistry (2017)